FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dana Selley

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Concepts & Ideas

Drug Dose Response Relationship

Co-author Network

Publications

TOP 3
Steven G Kinsey; Rehab Abdullah; Benjamin F Cravatt; Divya Ramesh; Dana E Selley; Laura E Wise; Aron H Lichtman
Repeated Low-Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains Cannabinoid Receptor Type 1-Mediated Antinociceptive and Gastroprotective Effects.
Lawrence C Blume; Steven R Childers; George D Dalton; Jasmine M Richardson; David C S Roberts; Dana E Selley; Ruoyu Xiao; Caroline E Bass; Allyn C Howlett
Striatal CB1 and D2 receptors regulate expression of each other, CRIP1A and δ opioid systems.
Sandra P Welch; Laura J Sim-Selley; Dana E Selley
Sphingosine-1-phosphate receptors as emerging targets for treatment of pain.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dana Selley (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Steven G Kinsey; Rehab Abdullah; Benjamin F Cravatt; Divya Ramesh; Dana E Selley; Laura E Wise; Aron H Lichtman
Repeated Low-Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains Cannabinoid Receptor Type 1-Mediated Antinociceptive and Gastroprotective Effects.
The Journal of pharmacology and experimental therapeutics 2013;345(3):492-501.
2013: Lawrence C Blume; Steven R Childers; George D Dalton; Jasmine M Richardson; David C S Roberts; Dana E Selley; Ruoyu Xiao; Caroline E Bass; Allyn C Howlett
Striatal CB1 and D2 receptors regulate expression of each other, CRIP1A and δ opioid systems.
Journal of neurochemistry 2013;124(6):808-20.
2012: Sandra P Welch; Laura J Sim-Selley; Dana E Selley
Sphingosine-1-phosphate receptors as emerging targets for treatment of pain.
Biochemical pharmacology 2012;84(12):1551-62.
2012: Yunyun Yuan; Feng Zhang; Zhenxian Zhang; Hamid I Akbarali; Shashidhar K Akubathini; Irina O Beletskaya; Jianyang Chen; William L Dewey; Orgil Elbegdorj; Phillip M Gerk; Krista L Scoggins; Dana E Selley; David L Stevens; Yan Zhang
Design, synthesis, and biological evaluation of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives as peripheral selective μ opioid receptor Agents.
Journal of medicinal chemistry 2012;55(22):10118-29.
2012: Peter T Nguyen; Kirsten M Raehal; Cullen L Schmid; Dana E Selley; Laura M Bohn; Laura J Sim-Selley
β-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner.
Biological psychiatry 2012;71(8):714-24.
2012: Yunyun Yuan; Christopher K Arnatt; Derong Ding; Kendra M Haney; Joanna C Jacob; Guo Li; Dana E Selley; Yan Zhang
Design and synthesis of a bivalent ligand to explore the putative heterodimerization of the mu opioid receptor and the chemokine receptor CCR5.
Organic & biomolecular chemistry 2012;10(13):2633-46.
2011: Laura J Sim-Selley; Antonino Sparta; Venetia Zachariou; Michael P Cassidy; Eric J Nestler; Dana E Selley
Effect of ΔFosB overexpression on opioid and cannabinoid receptor-mediated signaling in the nucleus accumbens.
Neuropharmacology 2011;61(8):1470-6.
2011: Laura E Wise; Kelly A Long; Lisa S Middleton; Dana E Selley; Laura J Sim-Selley; Stephen A Varvel; Jason M Wiebelhaus; Aron H Lichtman
delta(9)-Tetrahydrocannabinol-dependent mice undergoing withdrawal display impaired spatial memory.
Psychopharmacology 2011;217(4):485-94.
2011: Yunyun Yuan; Shashidhar K Akubathini; Irina O Beletskaya; Jianyang Chen; Orgil Elbegdorj; Dana E Selley; Yan Zhang
Structure selectivity relationship studies of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives toward the development of the mu opioid receptor antagonists.
Bioorganic & medicinal chemistry letters 2011;21(18):5625-9.
2011: Michelle R Hoot; Krista L Scoggins; Dana E Selley; Laura J Sim-Selley; William L Dewey
Chronic neuropathic pain in mice reduces μ-opioid receptor-mediated G-protein activity in the thalamus.
Brain research 2011;1406():1-7.
2011: Yunyun Yuan; William L Dewey; Phillip M Gerk; Hengjun He; Patrick Kozak; Guo Li; Pallabi Mitra; Krista L Scoggins; Dana E Selley; David L Stevens; Yan Zhang
Characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as novel leads to development of mu opioid receptor selective antagonists.
ACS chemical neuroscience 2011;2(7):346-51.
2011: Steven G Kinsey; Anu Mahadevan; Bingjun Zhao; Hang Sun; Pattipati S Naidu; Raj K Razdan; Dana E Selley; M Imad Damaj; Aron H Lichtman
The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects.
Neuropharmacology 2011;60(2-3):244-51.
2010: John W Huffman; Seon A Hepburn; Nataliya Lyutenko; Alicia L S Thompson; Jenny L Wiley; Dana E Selley; Billy R Martin
1-Bromo-3-(1',1'-dimethylalkyl)-1-deoxy-Δ(8)-tetrahydrocannabinols: New selective ligands for the cannabinoid CB(2) receptor.
Bioorganic & medicinal chemistry 2010;18(22):7809-15.
2010: P T Nguyen; Dana E Selley; Laura J Sim-Selley
Statistical Parametric Mapping reveals ligand and region-specific activation of G-proteins by CB1 receptors and non-CB1 sites in the 3D reconstructed mouse brain.
NeuroImage 2010;52(4):1243-51.
2010: Joel E Schlosburg; Jacqueline L Blankman; Jonathan Z Long; Daniel K Nomura; Bin Pan; Steven G Kinsey; Peter T Nguyen; Divya Ramesh; Lamont Booker; James J Burston; Elizabeth A Thomas; Dana E Selley; Laura J Sim-Selley; Qing-song Liu; Aron H Lichtman; Benjamin F Cravatt
Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system.
Nature neuroscience 2010;13(9):1113-9.
2010: James J Burston; Jenny L Wiley; Abimbola A Craig; Dana E Selley; Laura J Sim-Selley
Regional enhancement of cannabinoid CB₁ receptor desensitization in female adolescent rats following repeated Delta-tetrahydrocannabinol exposure.
British journal of pharmacology 2010;161(1):103-12.
2010: Katherine W Falenski; Andrew J Thorpe; Joel E Schlosburg; Benjamin F Cravatt; Rehab A Abdullah; Tricia H Smith; Dana E Selley; Aron H Lichtman; Laura J Sim-Selley
FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2010;35(8):1775-87.
2010: Michelle R Hoot; Laura J Sim-Selley; Justin L Poklis; Rehab A Abdullah; Krista L Scoggins; Dana E Selley; William L Dewey
Chronic constriction injury reduces cannabinoid receptor 1 activity in the rostral anterior cingulate cortex of mice.
Brain research 2010;1339():18-25.
2010: Tricia H Smith; Laura J Sim-Selley; Dana E Selley
Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?
British journal of pharmacology 2010;160(3):454-66.
2009: Laura J Sim-Selley; Paulette B Goforth; Mba U Mba; Timothy L Macdonald; Kevin R Lynch; Sheldon Milstien; Sarah Spiegel; Leslie S Satin; Sandra P Welch; Dana E Selley
Sphingosine-1-phosphate receptors mediate neuromodulatory functions in the CNS.
Journal of neurochemistry 2009;110(4):1191-202.
2009: Guo Li; Lindsey C K Aschenbach; Hengjun He; Dana E Selley; Yan Zhang
14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: design, synthesis, and biological studies.
Bioorganic & medicinal chemistry letters 2009;19(6):1825-9.
2009: Guo Li; Lindsey C Aschenbach; Jianyang Chen; Michael P Cassidy; David L Stevens; Bichoy H Gabra; Dana E Selley; William L Dewey; Richard B Westkaemper; Yan Zhang
Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists.
Journal of medicinal chemistry 2009;52(5):1416-27.
2008: Jenny L Wiley; Seth H Kendler; James J Burston; Daniel R Howard; Dana E Selley; Laura J Sim-Selley
Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in rats.
Neuropharmacology 2008;55(7):1183-90.
2008: James J Burston; Laura J Sim-Selley; John P Harloe; Anu Mahadevan; Raj K Razdan; Dana E Selley; Jenny L Wiley
N-arachidonyl maleimide potentiates the pharmacological and biochemical effects of the endocannabinoid 2-arachidonylglycerol through inhibition of monoacylglycerol lipase.
The Journal of pharmacology and experimental therapeutics 2008;327(2):546-53.
2008: Linda I Perrotti; R R Weaver; B Robison; William Renthal; I Maze; S Yazdani; R G Elmore; Darin J Knapp; Dana E Selley; B R Martin; Laura J Sim-Selley; Ryan K Bachtell; David W Self; Eric J Nestler
Distinct patterns of DeltaFosB induction in brain by drugs of abuse.
Synapse (New York, N.Y.) 2008;62(5):358-69.
2008: Diana L McKinney; Michael P Cassidy; Lauren M Collier; Billy R Martin; Jenny L Wiley; Dana E Selley; Laura J Sim-Selley
Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol.
The Journal of pharmacology and experimental therapeutics 2008;324(2):664-73.
2007: Jason L Niehaus; Yunguang Liu; Kathleen T Wallis; Michaela Egertová; Sheela G Bhartur; Somnath Mukhopadhyay; Shanping Shi; Hengjun He; Dana E Selley; Allyn C Howlett; Maurice R Elphick; Deborah L Lewis
CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a.
Molecular pharmacology 2007;72(6):1557-66.
2007: J Cory Kalvass; Emily R Olson; Michael P Cassidy; Dana E Selley; Gary M Pollack
Pharmacokinetics and pharmacodynamics of seven opioids in P-glycoprotein-competent mice: assessment of unbound brain EC50,u and correlation of in vitro, preclinical, and clinical data.
The Journal of pharmacology and experimental therapeutics 2007;323(1):346-55.
2007: Paul A Smith; Dana E Selley; Laura J Sim-Selley; Sandra P Welch
Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
European journal of pharmacology 2007;571(2-3):129-37.
2007: Laura J Sim-Selley; K L Scoggins; Michael P Cassidy; L A Smith; William L Dewey; Forrest L Smith; Dana E Selley
Region-dependent attenuation of mu opioid receptor-mediated G-protein activation in mouse CNS as a function of morphine tolerance.
British journal of pharmacology 2007;151(8):1324-33.
2006: Laura J Sim-Selley; Nicole Schechter; W Kirk Rorrer; George D Dalton; Jerry Hernandez; Billy R Martin; Dana E Selley
Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration.
Molecular pharmacology 2006;70(3):986-96.
2006: Steven W Paugh; Michael P Cassidy; Hengjun He; Sheldon Milstien; Laura J Sim-Selley; Sarah Spiegel; Dana E Selley
Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.
Molecular pharmacology 2006;70(1):41-50.
2006: Venetia Zachariou; Carlos A Bolanos; Dana E Selley; David E H Theobald; Michael P Cassidy; max kelz; Tamara Z Shaw-Lutchman; Olivier Berton; Laura J Sim-Selley; Ralph J DiLeone; Arvind Kumar; Eric J Nestler
An essential role for DeltaFosB in the nucleus accumbens in morphine action.
Nature neuroscience 2006;9(2):205-11.
2005: John W Huffman; Paul V Szklennik; Amanda Almond; Kristen Bushell; Dana E Selley; Hengjun He; Michael P Cassidy; Jenny L Wiley; Billy R Martin
1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles.
Bioorganic & medicinal chemistry letters 2005;15(18):4110-3.
2005: John W Huffman; Gulay Zengin; Ming-Jung Wu; Jianzhong Lu; George Hynd; Kristen Bushell; Alicia L S Thompson; Simon M Bushell; Cindy Tartal; Dow P Hurst; Patricia H Reggio; Dana E Selley; Michael P Cassidy; Jenny L Wiley; Billy R Martin
Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists.
Bioorganic & medicinal chemistry 2005;13(1):89-112.
2004: Diana L Cichewicz; Melinda L Cox; Sandra P Welch; Dana E Selley; Laura J Sim-Selley
Mu and delta opioid-stimulated [35S]GTP gamma S binding in brain and spinal cord of polyarthritic rats.
European journal of pharmacology 2004;504(1-2):33-8.
2004: Dana E Selley; Michael P Cassidy; Billy R Martin; Laura J Sim-Selley
Long-term administration of Delta9-tetrahydrocannabinol desensitizes CB1-, adenosine A1-, and GABAB-mediated inhibition of adenylyl cyclase in mouse cerebellum.
Molecular pharmacology 2004;66(5):1275-84.
2004: William Schwindinger; Kathryn E Giger; Kelly S Betz; Anna M Stauffer; Elaine M Sunderlin; Laura J Sim-Selley; Dana E Selley; Sarah K Bronson; Janet D Robishaw
Mice with deficiency of G protein gamma3 are lean and have seizures.
Molecular and cellular biology 2004;24(17):7758-68.
2004: Billy R Martin; Laura J Sim-Selley; Dana E Selley
Signaling pathways involved in the development of cannabinoid tolerance.
Trends in pharmacological sciences 2004;25(6):325-30.
2004: Chad M Thompson; Heidi Wojno; Elisabeth Greiner; Everette L May; Kenner C Rice; Dana E Selley
Activation of G-proteins by morphine and codeine congeners: insights to the relevance of O- and N-demethylated metabolites at mu- and delta-opioid receptors.
The Journal of pharmacology and experimental therapeutics 2004;308(2):547-54.
2003: Venetia Zachariou; Dan Georgescu; Nick Sanchez; Zia Rahman; Ralph J DiLeone; Olivier Berton; Rachael L Neve; Laura J Sim-Selley; Dana E Selley; Stephen J Gold; Eric J Nestler
Essential role for RGS9 in opiate action.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(23):13656-61.
2003: Zia Rahman; Johannes Schwarz; Stephen J Gold; Venetia Zachariou; Marc N Wein; Kwang Ho Choi; Abraham Kovoor; Ching-Kang Chen; Ralph J DiLeone; Sigrid C Schwarz; Dana E Selley; Laura J Sim-Selley; Michel Barrot; Robert R Luedtke; David W Self; Rachael L Neve; Henry A Lester; Melvin I Simon; Eric J Nestler
RGS9 modulates dopamine signaling in the basal ganglia.
Neuron 2003;38(6):941-52.
2003: Dana E Selley; J Taylor Herbert; Drake Morgan; charlie cook; Mitchell J Picker; Laura J Sim-Selley
Effect of strain and sex on mu opioid receptor-mediated G-protein activation in rat brain.
Brain research bulletin 2003;60(3):201-8.
2002: Forrest L Smith; Ruby R Javed; Mark J Elzey; Sandra P Welch; Dana E Selley; Laura J Sim-Selley; William L Dewey
Prolonged reversal of morphine tolerance with no reversal of dependence by protein kinase C inhibitors.
Brain research 2002;958(1):28-35.
2002: Laura J Sim-Selley; Amanda L Sharpe; Leslie J Vogt; Leah K Brunk; Dana E Selley; Herman H Samson
Effect of ethanol self-administration on mu- and delta-opioid receptor-mediated G-protein activity.
Alcoholism, clinical and experimental research 2002;26(5):688-94.
2001: Dana E Selley; C C Cao; Tammy Sexton; J A Schwegel; T J Martin; Steven R Childers
mu Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine.
Biochemical pharmacology 2001;62(4):447-55.
2001: Dana E Selley; W Kirk Rorrer; Christopher S Breivogel; AM Zimmer; Andreas Zimmer; Billy R Martin; Laura J Sim-Selley
Agonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G-protein activation.
Journal of neurochemistry 2001;77(4):1048-57.
2001: Laura J Sim-Selley; L K Brunk; Dana E Selley
Inhibitory effects of SR141716A on G-protein activation in rat brain.
European journal of pharmacology 2001;414(2-3):135-43.
2000: Dana E Selley; C C Cao; Q Liu; Steven R Childers
Effects of sodium on agonist efficacy for G-protein activation in mu-opioid receptor-transfected CHO cells and rat thalamus.
British journal of pharmacology 2000;130(5):987-96.
2000: Laura J Sim-Selley; Dana E Selley; Leslie J Vogt; Steven R Childers; T J Martin
Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2000;20(12):4555-62.
2000: Catherine E Maher; Dana E Selley; Steven R Childers
Relationship of mu opioid receptor binding to activation of G-proteins in specific rat brain regions.
Biochemical pharmacology 2000;59(11):1395-401.
2000: Laura J Sim-Selley; Leslie J Vogt; Ruoyu Xiao; Steven R Childers; Dana E Selley
Region-specific changes in 5-HT(1A) receptor-activated G-proteins in rat brain following chronic buspirone.
European journal of pharmacology 2000;389(2-3):147-53.
1998: Christopher S Breivogel; Dana E Selley; Steven R Childers
Cannabinoid receptor agonist efficacy for stimulating [35S]GTPgammaS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity.
The Journal of biological chemistry 1998;273(27):16865-73.
1998: Dana E Selley; Q Liu; Steven R Childers
Signal transduction correlates of mu opioid agonist intrinsic efficacy: receptor-stimulated [35S]GTP gamma S binding in mMOR-CHO cells and rat thalamus.
The Journal of pharmacology and experimental therapeutics 1998;285(2):496-505.
1998: LJ Sim; Q Liu; Steven R Childers; Dana E Selley
Endomorphin-stimulated [35S]GTPgammaS binding in rat brain: evidence for partial agonist activity at mu-opioid receptors.
Journal of neurochemistry 1998;70(4):1567-76.
1998: Dana E Selley; Christopher S Breivogel; Steven R Childers
Opioid inhibition of adenylyl cyclase in membranes from pertussis toxin-treated NG108-15 cells.
Journal of receptor and signal transduction research 1998;18(1):25-49.
1997: Thomas J Martin; LJ Sim; Dana E Selley; M G deMontis; Steven R Childers
Effects of intracerebroventricular administration of beta-funaltrexamine on DAMGO-stimulated [35S]GTP-gamma-S binding in rat brain sections.
Synapse (New York, N.Y.) 1997;27(3):177-82.
1997: Christopher S Breivogel; Dana E Selley; Steven R Childers
Acute and chronic effects of opioids on delta and mu receptor activation of G proteins in NG108-15 and SK-N-SH cell membranes.
Journal of neurochemistry 1997;68(4):1462-72.
1997: Dana E Selley; Eric J Nestler; Christopher S Breivogel; Steven R Childers
Opioid receptor-coupled G-proteins in rat locus coeruleus membranes: decrease in activity after chronic morphine treatment.
Brain research 1997;746(1-2):10-8.
1997: LJ Sim; Dana E Selley; Steven R Childers
Autoradiographic visualization in brain of receptor-G protein coupling using [35S]GTP gamma S binding.
Methods in molecular biology (Clifton, N.J.) 1997;83():117-32.
1997: Dana E Selley; LJ Sim; Ruoyu Xiao; Q Liu; Steven R Childers
mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy.
Molecular pharmacology 1997;51(1):87-96.
1996: LJ Sim; Dana E Selley; Ruoyu Xiao; Steven R Childers
Differences in G-protein activation by mu- and delta-opioid, and cannabinoid, receptors in rat striatum.
European journal of pharmacology 1996;307(1):97-105.
1996: LJ Sim; Dana E Selley; SI Dworkin; Steven R Childers
Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brain.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1996;16(8):2684-92.
1996: Dana E Selley; S Stark; LJ Sim; Steven R Childers
Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranes.
Life sciences 1996;59(8):659-68.
1995: LJ Sim; Dana E Selley; Steven R Childers
In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(16):7242-6.
1994: LJ Sim; Dana E Selley; K P Tsai; M Morris
Calcium and cAMP mediated stimulation of Fos in cultured hypothalamic tyrosine hydroxylase-immunoreactive neurons.
Brain research 1994;653(1-2):155-60.
1994: LJ Sim; Dana E Selley; K P Tsai; M Morris
D2 inhibition of stimulated Fos immunoreactivity in cultured tyrosine hydroxylase-ir hypothalamic neurons.
Brain research 1994;651(1-2):311-6.
1993: Steven R Childers; L M Fleming; Dana E Selley; R W McNutt; K J Chang
BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
Molecular pharmacology 1993;44(4):827-34.
1993: Dana E Selley; Christopher S Breivogel; Steven R Childers
Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins.
Molecular pharmacology 1993;44(4):731-41.